Cite
APA Citation
Wallace, D. J., Strand, V., Merrill, J. T., Popa, S., Spindler, A. J., Eimon, A., Petri, M., Smolen, J. S., Wajdula, J., Christensen, J., Li, C., Diehl, A., Vincent, M. S., Beebe, J., Healey, P., & Sridharan, S. (2017). efficacy and safety of an interleukin 6 monoclonal antibody for the treatment of systemic lupus erythematosus: a phase II dose-ranging randomised controlled trial. Annals of the rheumatic diseases, 76(3), 534–542. http://access.bl.uk/ark:/81055/vdc_100130160385.0x00005f